Patients treated with a monoclonal antibody (ab1) to the colorectal carcinoma antigen 17–1A develop a cellular response (DTH) to the “internal image of the antigen” (ab2)

This publication has 10 references indexed in Scilit:

• Monoclonal antibodies in cancer therapy
  Current Opinion in Immunology, 1990
• DEVELOPMENT OF ANTI-IDIOTYPIC ANTIBODIES AGAINST TUMOUR ANTIGENS AND AUTOANTIGENS IN OVARIAN CANCER PATIENTS TREATED INTRAPERITONEALLY WITH MOUSE MONOCLONAL ANTIBODIES
  The Lancet, 1988
• Possible role of anti-idiotypic antibodies in the induction of tumor immunity.
  Journal of Clinical Investigation, 1987
• Anti-idiotype immunization of cancer patients: modulation of the immune response.
  Proceedings of the National Academy of Sciences, 1987
• Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.
  The Journal of Experimental Medicine, 1985
• Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice.
  Proceedings of the National Academy of Sciences, 1984
• Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?
  Proceedings of the National Academy of Sciences, 1984
• Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies.
  Proceedings of the National Academy of Sciences, 1979
• Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines
  International Journal of Cancer, 1973
• Immunochemical and serological studies of enzymatically fractionated human IgG glubulins—I: Hydolysis with pepsin, papain, ficin and bromelin
  Immunochemistry, 1968